Hosted on MSN6mon
HUGE Stock Earnings: FSD Pharma Misses EPS for Q2 2024FSD Pharma (NASDAQ:HUGE) just reported results for the second quarter of 2024. FSD Pharma reported earnings per share of -8 cents. This was below the analyst estimate for EPS of -6 cents.
13d
Supervisory Board Freya Pharma’s new Supervisory Board From left to right: Manuel Voll, James E. Hattersley and Inez de ...
or the Company], a pharmaceutical company dedicated to developing effective therapies for women diagnosed with Female Sexual Disorders (FSD), today announced the formation of its Supervisory Board ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback